HIV

The Cost Implications to the Nigerian HealthCare System in effectively treating and Managing Patients with HIV

Abstract

Background: African nations are very fast increasing on HIV/AIDS treatment programs. Empirical information considering the cost of consigning antiretroviral treatment (ART) for HIV/AIDS is highly needed for program designing and budgeting.

Methods: I went through released and gray causes for direct cost approximates of supplying highly hardworking antiretroviral treatment (HAART) in service consignment backgrounds in Africa. I then reconsidered released studies notes the direct health charges of healing HIV-infected persons in nations in Sub-Saharan Africa.

Results: Of all conceivably apt studies, only 10 seemly cost approximates supplied sufficient facts and numbers to make any significant report about costs. Of these, 4 were from Nigeria. The cost per patient per year extended from $491 to $1180. It attained roughly $943.46016/patient/year in nations out-of-doors Nigeria and $826.91402/patient/year in Nigeria. Specific cost pieces utilised in the mean cost per patient per year differed, producing evaluation over studies difficult. All cost approximates encompassed the cost of antiretroviral pharmaceuticals and lab checks, but numerous omitted the cost of inpatient care, treatment of opportunistic diseases, and/or clinic infrastructure. Antiretroviral pharmaceuticals comprised an mean of one third of the cost of treatment in Nigeria and one half to three quarters of the cost in other nations looked at. Absolute assessments of total direct health charges between studies were not likely because of variations in the one-by-one constituents encompassed, the multifarious environment of study populations in periods of the causes and procedures engaged to approximate unit charges, and the grade of aggregation at which outcomes were reported.  

Conclusions: Essentially, there is very little empirical information accessible about the direct cost of supplying HAART in Nigeria, Africa. Methods for approximating charges are inconstant, and numerous approximates integrate facts and numbers drawn from diverse sources. Cost investigation should be examined as a benchmark part of operational study on the treatment rollout in Nigeria. The emergence of HAART has grave significances for the cost of healing HIV-infected individuals. Although this report is important for designing reasons, only a couple of released studies yield applicable approximates of the direct cost. An befitting procedure of approximating asset use and charges is computer simulation.

Furthermore, this critical exposition highlights that HIV/AIDS has (i) induced a substantial boost in the general problem of infection, (ii) crowded out the health resources booked for the care of customary sicknesses, (iii) granted increase to a gigantic boost in health expenditure paid for by families in poor nations and by the public part in the middle earnings ones and (iv) worsened the consignment capability of the whole health part as a outcome of increasing contamination rates amidst the employees and declining expenditure on maintenance.

Table of Contents

Chapter 1: Introduction6

1.1 Background Information6

1.1.1 The source of HIV6

1.1.2        Epidemiology7

1.1.2.1  Present Global Snapshot7

1.1.2.2 present position in Africa7

1.1.2.3    Current Situation In Nigeria8

Source: The World Fact publication August, 20108

1.1.3        Healthcare Resources Alloted To Hiv9

1.1.3.1  From A Global Context9

1.1.3.2  In Developed Countries (Upper/Middle-Income Countries)10

1.1.3.3   In Developing Countries (Lower/Middle-Income Countries)11

1.1.4        ...